Tag: EMA stability requirements

Checklist for Regional Regulatory Submission of Stability Data

Preparing a regulatory dossier that includes stability data is a cornerstone of pharmaceutical product approval. However, the format, documentation, and expectations for stability data vary significantly across agencies like the FDA, EMA, ASEAN, and TGA. This detailed checklist ensures your stability data package meets the expectations of each major region, based on ICH Q1A (R2)…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

Linking Protocol Design to Label Claim Shelf Life

Designing a stability study protocol isn’t just a procedural task—it directly influences the shelf life printed on the product’s label. Regulatory agencies such as the USFDA, EMA, and CDSCO expect a clear link between protocol structure and the justification for the expiry date. Without a robust design, your product may be assigned a shorter-than-necessary shelf…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Best Practices for Monitoring Frequency in Long-Term Stability Studies

Best Practices for Monitoring Frequency in Long-Term Stability Studies Optimizing Stability Monitoring Frequency in Long-Term Studies: A Guide for Pharma Professionals Stability testing over the long term is a regulatory requirement for assigning and maintaining a product’s shelf life. A key element of successful stability testing is selecting appropriate monitoring frequencies — the intervals at…

Real-Time and Accelerated Stability Studies, Stability Testing Types